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REVIEW

Dashing away hypertension: Evaluating the efficacy of the
dietary approaches to stop hypertension diet in controlling
high blood pressure
Preeya T Shah, Kyle D Maxwell, Joseph I Shapiro

Abstract

Preeya T Shah, Kyle D Maxwell, Joseph I Shapiro, Depart
ment of Medicine, Joan C. Edwards School of Medicine Marshall
University, Huntington, WV 25701-3655, United States

The dietary approaches to stop hypertension (DASH)
diet has been developed and popularized as a nonpharmaceutical intervention for high blood pressure
reduction since 1995. However, to date, a compre
hensive description of the biochemical rationale behind
the diet’s principal guidelines has yet to be compiled.
With rising interest for healthy and reliable life-style
modifications to combat cardiovascular disease, this
review aims to compile the most recent and relevant
studies on this topic and make an informed assess
ment as to the efficacy of and underlying mechanisms
operant in the DASH diet. Specifically, the merits of
lowering dietary intake of sodium and saturated fat, as
well as increasing the intake of fruits, vegetables, fiber,
and dairy, have been shown to attenuate hypertension
individually. Upon review of this evidence, we conclude
that the combination of dietary patterns proposed in the
DASH diet is effective in attenuating high blood pressure.
We also suggest that efforts to more widely implement
adoption of the DASH diet would be beneficial to public
health.

Author contributions: Shah PT and Maxwell KD both con
tributed equally to reviewing the research presented in the paper
as well as writing and editing this review; Shapiro JI acted as
corresponding author, and edited each draft of the manuscript for
submission.
Supported by The Huntington Foundation as well as Brickstreet
Insurance, HL109015, HL105649 and HL 071556.
Conflict-of-interest statement: The authors report no conflict
of interest for this article.
Open-Access: This article is an open-access article which was
selected by an in-house editor and fully peer-reviewed by external
reviewers. It is distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this
work non-commercially, and license their derivative works on
different terms, provided the original work is properly cited and
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/

Key words: Dietary approaches to stop hypertension
diet; Hypertension; Salt restriction; Oxidative stress;
Biochemistry

Correspondence to: Joseph I Shapiro, MD, Dean, Depart
ment of Medicine, Joan C. Edwards School of Medicine
Marshall University, 1600 Medical Center Dr, Huntington, WV
25701-3655, United States. shapiroj@marshall.edu
Telephone: +1-304-6911700
Fax: +1-304-6911726

© The Author(s) 2015. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: As a non-pharmaceutical intervention for
hypertension, the dietary approaches to stop hyper
tension (DASH) diet have emerged as the most prevalent
choice. Based on the principles of salt restrictions,
lowering fat and sugar intake, increasing fruit, vegetable,
and fiber intake, this program serves great promise
for patients diagnosed with high blood pressure. This
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from the JNC panel itself. In a paper published shortly
[10]
after the JNC 8, Wright et al cited insufficient evidence
for increasing the benchmark of treatment in patients
over 60, proposing that the goal BP eligible for treatment
[10]
should be lowered. Wright et al argued that increasing
the benchmark BP of this age group would also increase
the group’s risk of cardiovascular disease (CVD),
especially in high risk populations, and would undo the
progress of steadily decreasing levels of cardiovascular
mortality. The team proposed that it would be more
appropriate to raise the BP threshold for treatment
in individuals aged 80 and above, as the benefits of
[10]
therapy would be far more likely to exceed the risks .
For the purpose of this review, we refer to JNC 7 stages
of hypertension, due to the vast majority of research
published before the presentation of the new guidelines.
To help manage and attenuate disease pathogenesis,
intervention by way of lifestyle modification and/or
pharmaceutical therapies are strongly recommended.
However, due to the economic burden and potential
adverse side effects associated with pharmaceutical
therapies, a growing demand for alternate means of
treatment quickly arose. Consequently, before the turn of
the century, a dietary plan known as dietary approaches
to stop hypertension (DASH) was publicized after
successful results following two multicenter, randomized
[11-13]
outpatient feeding studies
. The principal guidelines of
[14]
the DASH diet (depicted in Table 1) focus on increased
consumption of fruits, vegetables, whole grains, fish,
poultry, beans, and seeds; in addition to consuming
low- and non-fat dairy products, the diet calls for limited
intake of: Sodium, saturated and trans fats, sugar, and
red meat. This diet further encourages consumption of
mineral-rich foods containing potassium, calcium, and
magnesium, and foods rich in fiber.
This review aims to breakdown and examine the
biochemical rationales behind specific tenets of the
DASH diet in an effort to evaluate its efficacy.

review aimed to assess the biochemical rational behind
the diet’s principle guidelines to evaluate the efficacy
of the DASH diet in the treatment of hypertension. We
conclude that the combined tenets of the DASH diet are
effective in lowering blood pressure.
Shah PT, Maxwell KD, Shapiro JI. Dashing away hypertension:
Evaluating the efficacy of the dietary approaches to stop
hypertension diet in controlling high blood pressure. World J
Hypertens 2015; 5(4): 119-128 Available from: URL: http://
www.wjgnet.com/2220-3168/full/v5/i4/119.htm DOI: http://
dx.doi.org/10.5494/wjh.v5.i4.119

INTRODUCTION
Currently suspected as an underlying cause of ap
proximately 7.1 million (13% of) deaths worldwide,
[1]
hypertension remains a prevalent affliction . To com
plicate the matter, the etiology of primary (essential)
hypertension which accounts for 90%-95% of adult
[2]
cases is still unclear . Uncontrolled hypertension serves
to be a major risk factor for the development of a
[3]
[4]
[5]
multitude of neural , cardiac , and renal disorders.
Similar to the “All roads lead to Rome” adage, several
factors have been implicated in the pathogenesis of
hypertension including, but not limited to: Oxidative
stress, genetic factors, renal injury, inadequate nutrient
intake, overproduction of sodium retaining hormones,
disruption of the renin-angiotensin or kallikrein-kinin
[6]
systems, deficiencies in vasodilators . This review
utilized studies dating back to the early 1900’s in order to
establish a background for the research being conducted
today, however, the majority of data compiled for review
[7]
in this paper was conducted from the INTERSALT study
in 1988 through present day.
Until recently, hypertension has been classified into
three stages that increase in severity: Pre-hypertension,
[systolic blood pressure (BP) of 120-139 mmHg and
diastolic BP of 80-89 mmHg], stage 1 (systolic BP of
140-159 mmHg and diastolic BP of 90-99 mmHg), and
stage 2 (systolic BP of 160-179 mmHg and diastolic
BP of 90-99 mmHg). These classifications arose in
th
[8]
2003 with the 7 JNC report on hypertension . More
th
recently in 2014, the 8 JNC report was released to the
th
public. The 8 edition of the report modified the above
specifications, and took an alternate approach regarding
the BP threshold of intervention, which treatment should
be administered, and also the target BP to be achieved.
JNC 8 proposes to begin treatment for those over the age
of 60 at an increased BP threshold of > 150/90 mmHg,
while the goal BP for those below the age of 60 is still <
[9]
140/90 . The change originated from multidisciplinary
analysis of many randomly controlled trial studies. The
idea behind this decision was based on the reevaluation
of the risks of side effects vs the benefits of treatment of
[9]
hypertension . A great deal of controversy has arisen
th
surrounding the 8 JNC report, some dissent arising
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Dietary Sodium Restriction
Sodium plays an integral role in the biomechanical
function of muscle and nerve fibers, and is largely
responsible for the auto regulation of fluid balance at
the cellular level. Yet, similar to other essential nutrients,
excessive sodium levels can yield damaging effects
physiologically. Research has delved into the relationship
between sodium intake and hypertension for the past 50
years, and it is widely regarded as a major component
[15]
to the development of high BP . Investigators Ambard
[16]
et al first evidenced this relationship in 1904, in which
six hypertensive patients were placed on three separate
diets with modified salt and protein content. Outcomes
of the study revealed that sodium content, irrespective
of protein content, was inversely related to BP within and
across each diet. Specifically, when sodium intake was
reduced, corresponding decreases in BP were observed.
Similar beneficial effects of dietary sodium restriction
were reported in 1948, when Walter Kempner’s Rice
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Increased sodium intake
Upregulation of alpha adrenergic receptors
Volume expansion
Decreased SNS activity

Upregulation of AT2 and Aldo receptors

Decreased RAAS activity
Shift in salt sensitivity

Renal fibrosis
Increased natriuretic peptides

Hypertension

Increased oxidative stress

Increase in CTS

Sodium homeostasis

Figure 1 Schematic summarizes tradeoff by which physiological mechanisms that lead to sodium homeostasis in face of increased sodium intake might,
over time, lead to a shift in salt sensitivity and sustained hypertension. SNS: Sympathetic nervous system; RAAS: Renin, angiotensin, aldosterone, system;
CTS: Cardiotonic steroids; AT2: Angiotensin Ⅱ; Aldo: Aldosterone.
[18]

manner . In 1988, the monumental Intersalt study
was compiled. Examining approximately 10000 patients
from 52 examination centers worldwide, Intersalt
remains the largest study of its kind to date. The major
findings extended over international population and
individual levels, and supported the direct correlation
between sodium intake and hypertension. Regional
differences in salt intake were also found to correlate
with regional levels of hypertension. Perhaps of even
greater relevance, the increases in systolic BP noted with
age appeared to correlate on a population level even
[7]
better with sodium intake than absolute levels of BP .
Although the relationship between salt and BP is
readily accepted, the exact biochemical mechanism
behind salt’s role in the development of hypertension
remains unclear. The renal renin-angiotensin-aldosterone
system (RAAS) appears to be largely implicated in the
development of salt driven hypertension and is the
site of many pharmacological treatments for stage 2
hypertension, including angiotensin-converting enzyme
(ACE) inhibitors and angiotensin Ⅱ (Ang Ⅱ) receptor
[19]
blockers .
Under physiological conditions, high salt diets typically
suppress Ang Ⅱ levels through BP control mechani
[20]
sms . Despite this, 40%-50% of patients with essential
hypertension do not engage this expected renal response
to Ang Ⅱ and thus, do not react appropriately to changes
[20,21]
in dietary sodium intake (depicted in Figure 1)
. This
is one avenue of salt sensitivity, and while it has been
documented clinically, its mechanisms have yet to be
[22,23]
resolved
. Salt sensitivity has also been attributed to
[24]
genetic mutations of the renin and ACE genes . These
individuals appear to exhibit high BP and low plasma
[25]
renin levels in response to salt intake .
Additionally, RAAS, nitric oxide (NO), and superoxide
anion (O2 ) in the kidney, work together in a regulatory
fashion. Activation of RAAS leads to the production of

Table 1 Breaking down the dietary approaches to stop
hypertension diet
Food group

Daily servings

Nutritional value

Grains/dietary fiber
Vegetables

7-8
4-5

Fruits

4-5

Protein (poultry, fish,
etc.)
Low and non-fat dairy

2-5

Nuts, seeds, and dry
beans
Fats and oil

4-5

Rich in dietary fiber
Rich in nitrate, fiber, potassium,
and magnesium
Rich in nitrate, fiber, potassium,
and magnesium
High in bioactive proteins and
magnesium
High in calcium, vitamin D, and
bioactive proteins
High in potassium, magnesium,
proteins, and fiber
Accounts for 27% of caloric
intake and essential fats and oils
Sweets should be low in fat

Sugar

2-3

2-3
5 per week

A breakdown of the dietary approaches to stop hypertension (DASH) diet
by food group, serving size per diem, and the nutritional goal of each of
the DASH guidelines. These specific guidelines have been endorsed and
published by the National Institutes of Health[14].

Diet became publicized. The initial study involved 500
hypertensive patients placed on a diet predominantly
consisting of rice, supplemented with fruits. Dietary
salt content was maintained below 500 mg, and the
subsequent effects of the diet were tremendous; along
with attenuation of high BP, the patients’ demonstrated
reduced cardiac hypertrophy and amelioration of
[17]
hypertensive retinopathy . Although the practicality of
maintaining this fairly tasteless diet proved bleak, the
implications of the study were inescapable.
[18]
More recently, in 1980 Srinivasan et al
tested
the effects of a high salt vs high salt/sucrose diets on
spider monkeys. Findings from the study indicated that
both high salt and high salt/sucrose diets resulted in
elevated BP, and most importantly, in a dose-dependent
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O2 , a vasoconstrictor, and NO, a vasodilator, and both
molecules readily react with one another. Dysfunction
within the RAAS can lead to an imbalance of NO and
O2 , which has been linked to salt sensitivity and hyper
[26,27]
tension
. In short, high levels of dietary sodium
appear to induce inappropriate RAAS activity, leading
[28]
to vascular maladaptation . While certainly not the
only avenue of hypertension, these studies highlight
the importance of the RAAS in management of hyper
tension.
Sustained levels of high dietary sodium intake have
been implicated not only in the pathogenesis of hyperten
sion, but also albuminuria, altered gene expression, and
[29]
even renal structural damage . Further experiments
have been crafted to test the efficacy of lowering
[30]
sodium intake on hypertensive patients. He et al
demonstrated that a diet modified to lower only sodium
content, with no other dietary restrictions, caused a
significant reduction in BP in both normotensive and
hypertensive patients. Moreover, as recently as 2015, a
[31]
study conducted by Barros et al highlighted the use of
“light salt”, a salt developed with lower sodium content
and higher potassium levels as a significantly effective
agent in reducing BP.
The first major tenet of the DASH diet is a substantial
[11]
reduction in sodium intake . It is estimated that the
average adult American consumes roughly 3700 mg of
sodium per day; by contrast, the DASH diet recommends
that dietary sodium should be limited to < 2300 mg/d
[32]
(< 1500 mg/d for high-risk individuals) . In a com
prehensive analysis of the effect of sodium consumption
[33]
on BP, Bray et al evaluated variations of sodium intake
within the context of the standard American diet vs the
DASH diet. In total, the study consisted of six groups: A
control diet similar to the standard American diet and a
DASH diet group were each divided into low, moderate,
[33]
and average (high) sodium groups . The researchers
demonstrated a dose-dependent relationship between
sodium consumption and BP; the findings corresponded
with the results of previous experiments (discussed
above): The lower the sodium intake, the greater the
drop in BP. Furthermore, while both control and DASH
groups experienced a drop in BP, limiting dietary sodium
had an additive relationship when coupled with the DASH
diet; these results demonstrate that patients consuming
lower dietary sodium, in accompaniment with the rest of
the DASH dietary patterns, experience an even greater
[30,33]
drop in BP
. Biochemical analysis of the DASH diet
yield similar optimistic results. Using the same six-group
[33]
approach as Bray et al , analysis was performed by
examining their corresponding pressure-natriuresis
curves. The DASH diet appeared to decrease tubular
sodium reabsorption without increasing glomerular
[34]
filtration rate ; thus, the DASH diet is natriuretic in a
sustainable way. Compiling the evidence-based research
together, as a whole, we find overwhelming support of
sodium restriction aiding the efficacy of the DASH diet in
controlling hypertension.

WJH|www.wjgnet.com

Effects of Increasing Fruit and
Vegetable Intake
As discussed above, the origin and development of
hypertension is complex, yet substantial literature also
suggests that a sustained increase in peripheral vascular
resistance due to arterial structural remodeling plays a
[6,35,36]
prominent role in the pathogenesis of this disease
.
3
Research suggests that the high inorganic nitrate (NO )
content present in many vegetables may play vasopro
[37-39]
[40]
tective
and cardioprotective roles, via endogenous
conversion to NO - a potent vasodilator. Consequently,
endothelial dysfunction often characterized by a
reduction in NO bioavailability has been largely implicated
[41-43]
in patients with essential hypertension
. Discussion
considering the physiological biosynthesis and function of
[40,44-48]
NO can be found in several references
.
It is estimated that the largest source of dietary
nitrates (roughly 80%) comes directly from vegetable
consumption; alternate dietary sources of nitrate and
nitrite (a reduced form of nitrate) can also be found in
[38]
fruits, vegetables, and processed meats . In 2008,
[37]
Webb et al provided the first clinical evidence support
ing the vasoprotective role of dietary nitrate harbored
by a vegetable-rich diet in normotensive volunteers. The
team of researchers utilized beetroot juice to display that
consumption of an acute nitrate load corresponds with
a significant reduction of both systolic and diastolic BP,
as well as a reduction of platelet activation; these effects
appear to be associated with the simultaneous rise in
[37]
circulating nitrite levels via entero-salivary conversion
of the original dietary nitrate load, and further reduction
[37,49,50]
of nitrite to NO
.
The DASH diet calls for 4-5 servings of fruits and
4-5 servings of vegetables per day (based on a 2000
calorie diet); the range of daily servings per food group
may fluctuate depending on an individual’s daily caloric
needs, which take one’s age and activity level into
[14]
account . In response to the substantial literature
present supporting the physiological benefits of dietary
[38]
nitrate and nitrite, Hord et al extended these findings
to assess the high fruit and vegetable recommendations
emphasized by the DASH diet. The researchers utilized
High-performance liquid chromatography (HPLC) on a
convenience sample of foods in order to quantify and
compare various nitrate and nitrite concentrations.
Results from HPLC indicated a wide range of nitrate and
nitrite content amongst various fruits and vegetables.
From this data, the researchers generated two hypo
thetical high- and low-nitrate vegetable and fruit DASH
diet patterns (i.e., 1222 mg nitrate vs 174 mg); the
analysis revealed that the general dietary pattern of
fruits and vegetables outlined in the DASH guidelines
have the potential to vary drastically in terms of nitrate
[38]
intake, based on specific vegetable and fruit selection .
The results further suggest that simply increasing fruit
and vegetable intake does not directly translate to
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higher dietary nitrate and nitrite consumption, this may
alter the extent of vasoprotective and cardioprotective
implications mediated by these molecules (as discussed
above).
In the pathologic state, increasing evidence implicates
oxidative stress to largely influence the induction and pro
[51]
gression of hypertension . The unregulated production
of reactive oxygen species (ROS) can largely disrupt
[52,53]
function of essential cellular lipids and proteins
. Accor
dingly, several natural antioxidant components of fruits
and vegetables (i.e., vitamins, minerals, polyphenols)
are shown to assist the bodies’ ROS scavenging system
via multiple mechanisms, and are greatly implicated in
[54-56]
controlling high BP and endothelial dysfunction
. The
rich vitamin and mineral content found within fruits and
vegetables contribute to both the enzymatic and nonenzymatic (direct ROS scavengers) antioxidant defense
[57]
systems . In regards to enzymatic ROS quenching,
many of these enzymes exist as metalloenzymes.
Three isoforms of superoxide dismutase help confer
vascular protection as potent defenders of superoxide via
[58]
dismutation , and utilize metals such as zinc, copper,
and manganese. Additionally, glutathione peroxidases
readily quench reactive hydrogen peroxide (by product
of previous reaction), and are selenium-dependent
[57]
enzymes . Fruits and vegetables are often great sources
of these essential minerals, and thus can contribute to
enzymatic ROS defense.
In a similar vein, other micronutrients abundant in
fruits and vegetables further bolster antioxidant defense
by non-enzymatic means via direct scavenging of ROS.
Lipid-soluble vitamin E and water-soluble vitamin C are
[59]
both capable of reacting with peroxyl radicals . It was
later reported that vitamin E might synergistically interact
with vitamin C in order to enhance its role as a peroxyl
[60]
[61]
radical scavenger . Additionally, Pierdomenico et al
observed drastically reduced plasma levels of vitamin C
in hypertensive patients compared to their normotensive
[62]
counterparts. Subsequently, Block et al supported this
observation by demonstrating that vitamin C depletion
in normotensive subjects resulted in increased diastolic
[62]
and systolic BP . However, it should be noted that
[63]
[64]
the relative antioxidant capacity
and content
of
various constituents in fruits and vegetables is variable.
This disparity is seen with plant-derived polyphenolic
flavonoids, which are found to possess nearly four times
[63]
the antioxidant activity than vitamin E analogue .
As of recent, fructose and its relation to BP has been
a popular topic of contention. In the United States,
this monosaccharide - naturally available in fruits is most abundantly obtained from added fructoseglucose sweeteners such as, table sugar (sucrose) and
[65]
high-fructose corn syrup . Although, high fructose
consumption is evidenced to be associated with insulin
[66]
[67,68]
[69]
resistance , obesity
, and renal
complications,
[70-72]
epidemiological studies are controversial
; moreover,
the source of dietary fructose may be of importance.
The rich antioxidant properties associated with fruits
(discussed above) may counter the potential harmful
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effects suggested by fructose. While this relationship or
[70]
mechanism has yet to be established, Forman et al
found no association with fructose consumption and
hypertension, in which individuals consumed a high
intake of fruits. Excluding fructose content from natural
fruit, a 2010 cross sectional analysis of United States
adults with no prior history of hypertension reported an
independent association between high fructose intake
[71]
(from added sugar) and elevated BP . Cumulatively,
the multitude of micronutrients found in fruits and
vegetables (as evidenced above) make them a beneficial
and necessary inclusion in the major tenets of the DASH
diet program.

Benefits of Fat-free and Low-fat
Dairy Products
Dairy products and fatty acids are closely intertwined
biochemically, and comprise one of the major tenets of
the DASH diet program. The effect of saturated fats on
BP has been a popular research topic during the last
twenty years. It has been observed that populations
consuming diets low in both total and saturated fats,
[73]
are often the ones exhibiting low to moderate BPs .
Analysis of three vegetarian diets: the first consisting
of high carbohydrates and low fat, the second high in
polyunsaturated fat, and the third low in saturated fat
content, revealed that all conditions were shown to
[73-75]
reduce BP in their respective populations
. Further
support for the relationship between dietary saturated fat
content and BP was demonstrated by a study compiled
in Finland; the experimental group that consumed high
levels of saturated fats subsequently had higher BP than
[76,77]
their control counterparts
.
Unlike saturated fatty acids, diets high in polyun
[78]
[79]
saturated fats
and monounsaturated fats
have
been shown to have an inverse relationship with BP.
Fish oil, high in polyunsaturated fat, has been shown to
have protective effects against the risk factors for CVD,
[80]
including hypertension . The fatty acids found in fish
oil are precursors for 3-series prostaglandins, known
[81]
for their antiaggregatory and vasodilator properties ;
furthermore, polyunsaturated fats (such as linoleic acid
and those found in fish oil) have been shown to lower
low-density lipoprotein (LDL) cholesterol levels. This is
vitally important in protection against CVD because the
oxidized form of LDLs are absorbed by macrophages,
creating foam cells that latch onto the walls of arteries,
[82]
[81]
leading to atherosclerosis . Frenoux et al
study
went on to show that polyunsaturated fatty acids had
antihypertensive effects, and also boosted resistance to
free radical aggregation and lipid peroxidation.
Dairy, in contrast, consists of a more complex makeup
of constituents: 89% water, 3.5% protein, 4.6% car
[83]
bohydrates, and 3.3% lipid . The protein constituents in
dairy products are made up of bioactive peptides, known
[84]
as lactotripeptides , and are similar to those found in
lean red meat; both varieties of bioactive peptides have
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[85]

[99,100]

been shown to block ACE . The lipid components of
dairy products generally consist of about 60% saturated
[86]
fatty acids (FA) and about 30% unsaturated FA . The
other about 10% consist of short to medium length FA
chains that are readily absorbed into the bloodstream,
where they preferentially become oxidized rather than
stored as triglycerides; and, in short, is associated with
[86,87]
weight loss
. An inverse relationship was found to
exist between dairy intake and BP; and, this relationship
was strengthened if saturated fat intake was below about
[88]
11% .
Additionally, dairy intake, while not associated with
overall mortality, appears to be inversely related to the
multitude of risk factors for CVD including hyperten
[89]
[84]
sion . More recently, Drouin-Chartier et al
reported
dairy intake to improve endothelial function and attenuate
mild to moderate hypertension. Subsequent studies
have shown that vitamin D alone also displays a curative
[90]
effect on hypertension and other CVD risk factors .
The body of evidence here supports the DASH diet’s
recommendations in emphasizing the consumption of fatfree and low-fat dairy products, as well as reducing the
intake of saturated and trans fats.

antioxidants) and other nutrients
. A 4-fold decrease
was seen in the cardiovascular death rate between men
who ingested a high fiber diet (> 37 g/d) vs those who
[101]
ingested a low fiber diet (< 20 g/d) . Similar results
were demonstrated, during a 6-year prospective study, in
which an inverse relationship was found between dietary
[102]
fiber intake and CVD rates . Additionally, cereal fiber
was revealed to be strongly associated with a reduction
in CVD death rates; this result was further supported by
[103,104]
the documented protective nature of whole grains
.
Adding support to the inverse relationship between
dietary fiber and cardiovascular risk factors, Lairon et
[105]
al
further demonstrated that this correlation existed
for all forms of fiber (Soluble, insoluble, fruits, grains,
vegetables, cereal, etc.), specifically in regards to the
prevalence of hypertension. While mechanistic data
is yet to be confirmed, it is thought to be associated
with a reduction of abdominal obesity and increased
[105]
vascular reactivity
. Fiber has also been shown to
attenuate endothelial dysfunction associated with hyper
[106]
cholesterolemia ; this finding suggests that fiber may
indirectly play a protective role against hypertension,
as the endothelium serves as an important regulator
of vascular tone in response to altering needs for blood
[107,108]
amongst different organs and tissues
. Taken
together, a substantial body of evidence suggests that
increasing dietary fiber plays a beneficial role in the
battle against hypertension.

RICH ENERGY SOURCES: WHOLE
GRAINS AND DIETARY FIBER
Dietary fiber is the indigestible cell wall component found
[91]
in plants . It is divided into two categories, soluble fiber
and insoluble fiber. Soluble fibers include pectins, gums,
mucilages, and some hemicelluloses; alternatively, insolu
ble fibers include lignins, cellulose, and the remainder
[92]
of the hemicelluloses . Early studies, conducted by
[93]
Burkitt
in 1975, demonstrated that low dietary fiber
intake is linked to many diseases, such as cardiovascular
disease. This lent credence to the idea that dietary
fiber may also be related to hypertension, a major risk
factor in CVD. The recommended daily intake value of
[94]
dietary fiber is between 20-35 g/d . This is twice the
amount of fiber that the average American typically
[95]
consumes . Initially, studies sought to analyze highfiber vegetarian diets, which were previously shown to
[91]
attenuate hypertension . Subsequently, there was a
rise in controversy; critics suggested that the decrease
in BP seen in these studies could have easily arisen
from other factors present in a vegetarian diet. Another
setback arose with the discovery that increases in
dietary fiber alone had little to no effect on normotensive
[96]
patients .
Despite these setbacks, new research emerged
showing the benefits of dietary fiber in regards to cardiac
[97]
distress. In 1997, Stamler et al
demonstrated an
inverse relationship between increased dietary fiber
intake and BP. Additionally, whole grains were shown
[98]
to be associated with lowering BP . Whole grains
themselves offer much nutritional value, providing
complex carbohydrates, resistant starch, dietary fiber,
minerals, vitamins, phytochemicals (which serve as
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CONCLUSION
The DASH diet has provided the general public with a
non-pharmaceutical option to combat hypertension. The
last twenty years have been filled with studies breaking
down each aspect of the DASH program. Many of these
studies showed great success in highlighting the benefits
of lowering sodium and saturated fat intake, while
increasing intake of fruits, vegetables, dairy, and dietary
fiber. However, the biochemical mechanisms behind these
dietary guidelines have only been vaguely illuminated.
Dietary biochemistry itself is a very complex story to tell,
consisting of a diverse array of mechanistic pathways
and byproducts. Although a complete understanding of
each of these mechanisms and their implications has not
yet been established, substantial effort has been made
to fill in the gaps. This review attempted to compile the
most recent available research in order to paint as vivid
a picture as possible of how individual aspects of the
DASH diet effect BP, and ultimately draw a conclusion
as to the efficacy of such a diet for the treatment of
hypertension. Despite the limitations of the total scope of
our analysis, the abundant evidence in support of these
dietary modifications is compelling, and we recommend
the DASH diet to be an effective non-pharmaceutical
treatment of hypertension. Further publicity and
implementation could dramatically reduce the number
of hypertensives both nationally and internationally.
In American culture, focus should be placed on the
maintainability of the diet. Stigmata has been placed
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on healthy diets for being overly expensive, and out of
[109]
reach for the average family. According to Sacks et al ,
the DASH program should cost approximately $130.00
per week for a family of 4. Adjusting for inflation, this
translates to less than $200.00 per week today, still a
very low total for a family of 4. Internationally, focus
should be shifted to modification of diets depending on
the cultural tendencies of the various groups of people
who are regionally predisposed to high salt diets. These
actions taken together could have a great impact on the
health of individuals worldwide. Future research will need
to elucidate the biochemical mechanisms inherent in
the DASH diet. This could lead to further, more tailored
and effective, dietary modifications for the masses; we
predict that as further comprehensive understanding of
this anti-hypertensive diet grows, we will see an overall
attenuation of this disease.
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